During the "Twelfth Five-Year Plan" period, it is a crucial period for the transformation and upgrading of medical equipment in China. With the further deepening of medical reform, the trend of aging in the next 20 years will be further aggravated, the continuous expansion of urban medical and health institutions, and the continuous improvement of people's medical health awareness will further open up the capacity of the local medical device market in the future. All along, China's new medical devices are far from the developed countries, and most of the products have lower added value. Although these labor-intensive products are currently selling well, the pressure of homogenization competition from Southeast Asian countries such as Vietnam and Thailand is increasing, and their profit margin will gradually shrink. In the fierce market competition, medical device companies are likely to face a major reshuffle. How to make a clear judgment on the current and trend of industry competition has become the key to our medical device industry to seize the opportunity of market expansion and enhance the international status of the industry. The status quo of China's medical device industry can be summarized as: the vertical monopoly of the international giant industry chain, and the continued substitution of local import substitution. Specifically, the following characteristics are presented: Foreign medical device companies extend from high-end products to low-end products Multinational corporations have an absolute advantage in the high-end medical equipment market in China, especially in areas with high technical barriers such as medical imaging equipment and in vitro diagnostics. The market share is over 75%. Chinese medical institutions spend huge amounts of foreign exchange every year to import large quantities of medical equipment. . Domestic tertiary hospitals generally use imported medical devices. Even in secondary hospitals, two-thirds of medical devices are imported products. Specifically, in China's medical device field, about 80% of the CT market, 90% of the ultrasonic instrument market, 85% of the test instrument market, 90% of the magnetic resonance equipment, 90% of the electrocardiograph market, 80% of the high-end The monitor market and 90% of the high-end physiological recorder market are monopolized by multinational companies. However, with the saturation demand for high-end equipment preparation in large domestic hospitals, the demand for high-end medical devices has slowed down. In the context of “health reformâ€, the rural market has also become a potential market for multinational companies to compete for. In order to consolidate and expand its market share in China's medical device market, multinational companies are actively cooperating with Chinese companies and localizing research and development. Such means to penetrate into the low-end market. For example, GE Healthcare has vigorously promoted localized research and development in recent years, and its “portable ultrasound system†for rural and poor areas has made a huge contribution to its growth rate of 25% in the Chinese market. Medtronic cooperates with Shandong Weigao to operate orthopaedic equipment products through the first investment and then joint venture. It plans to open up the low-end market through the strong marketing capabilities and channels of Weigao in the second and third-tier cities, and at the same time step up the pace of research and development to promote localization. Small and medium-sized medical devices are mainly exported, and the import substitution trend of medium and high-end products is obvious. For a long time, because China's imported products are mainly large-scale precision medical equipment produced by developed countries in Europe and America, and the export products are mainly small and medium-sized products such as medical consumables, massage equipment and conventional equipment. In the import and export of medical equipment, it is in a deficit position. With the improvement of R&D and production level in China, the gap between technology and foreign medical device production technology has gradually narrowed; conventional medical device equipment has basically achieved independent production, and products with independent intellectual property rights of high-end medical equipment are gradually imported and replaced, and some products are exported to overseas markets in batches. This shows that China’s export deficit has gradually narrowed, and the surplus was achieved for the first time in 2005. From the perspective of export value, Europe, America and Japan are still the main export markets for medical device products in China. The vast number of developing countries, including the Middle East countries and Latin American countries, account for only 10% of China's exports of medical device products. This shows that although developed countries in Europe and the United States have experienced the cold of the economic crisis, they still have huge import strength. In recent years, China's exports of high-end diagnostic instruments to Europe, the United States and Japan are increasing. Last year, China’s exports of medical devices to Russia, Brazil, Ukraine and other countries soared by 43%, making these countries a new hot market for medical device exports. Medical Plaster,Plasters Sprain Plaster,Plaster For Injury,Waterproof Plaster Patch Puyang Degren Medical Equipment Co., Ltd. , https://www.degrenyuwei.com